TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments
  • Shareholders Foundation monitors Class Action Investigations, Cases, and Class Action Settlements.
    Learn More >>>
  • Create Notifications and monitor one Case or multiple Cases. Or submit your entire portfolio! Learn More >>>

Ligand Pharmaceuticals Inc (NASDAQ: LGND) Investor Securities Class Action Lawsuit 11/17/2016

  • If you purchased shares of Ligand Pharmaceuticals Inc (NASDAQ: LGND), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

May 16, 2017 - The case was voluntarily dismissed. November 17, 2016 - An investor in shares of Ligand Pharmaceuticals Inc (NASDAQ: LGND) filed a lawsuit in the U.S. District Court for the Southern District of California over alleged violations of Federal Securities Laws by Ligand Pharmaceuticals Inc in connection with certain allegedly false and misleading statements made between Nov...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)